Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Shanghai MicroPort MedBot (Group) Co., Ltd. Class H ( (HK:2252) ) has provided an update.
Shanghai MicroPort MedBot (Group) Co., Ltd. has established terms of reference for its Audit Committee to enhance decision-making and oversight processes. The Audit Committee is tasked with supervising internal and external audits, ensuring effective internal controls, and providing accurate financial reporting, thereby strengthening the company’s governance and operational transparency.
The most recent analyst rating on (HK:2252) stock is a Sell with a HK$20.00 price target. To see the full list of analyst forecasts on Shanghai MicroPort MedBot (Group) Co., Ltd. Class H stock, see the HK:2252 Stock Forecast page.
More about Shanghai MicroPort MedBot (Group) Co., Ltd. Class H
Shanghai MicroPort MedBot (Group) Co., Ltd. is a joint stock company incorporated in China, operating within the medical technology industry. The company focuses on developing innovative medical robotic solutions, enhancing healthcare delivery and patient outcomes.
Average Trading Volume: 5,962,532
Technical Sentiment Signal: Buy
Current Market Cap: HK$22.42B
For detailed information about 2252 stock, go to TipRanks’ Stock Analysis page.